These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 15481703

  • 1. "Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen.
    Giacosa R, Santi R, Vaglio A, Pavone L, Ferrozzi F, Passalacqua R, Buzio C.
    Acta Biomed; 2004 Aug; 75(2):126-30. PubMed ID: 15481703
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A case of interferon-alpha-resistant renal cell carcinoma responding to interleukin-2 therapy].
    Kobori G, Yamada H, Higashi Y.
    Hinyokika Kiyo; 2008 Oct; 54(10):657-9. PubMed ID: 19048930
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of renal cell carcinoma with mediastinal lymph node metastasis by interleukin-2: a case report.
    Tokunaga M, Masuda A, Mukai M, Nakamura H, Iwaki K, Terachi T.
    Tokai J Exp Clin Med; 2005 Jul; 30(2):111-5. PubMed ID: 16146201
    [Abstract] [Full Text] [Related]

  • 8. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
    Sakata Y, Ogura Y, Wakita T, Hayashi N, Sugimura Y.
    Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Individualized therapy with alpha-interferon in metastatic renal cell carcinoma].
    Gross AJ, Dieckmann KP, Krain J, Huland H.
    Urologe A; 1995 Mar; 34(2):158-61. PubMed ID: 7754588
    [Abstract] [Full Text] [Related]

  • 11. [Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
    Terachi T, Okada Y, Takeuchi H, Yoshida O.
    Hinyokika Kiyo; 1993 Apr; 39(4):353-5. PubMed ID: 8503332
    [Abstract] [Full Text] [Related]

  • 12. Regression of pulmonary and multiple skeletal metastases from renal cell carcinoma by nephrectomy and alpha-interferon therapy: a case report.
    Ibayashi K, Ando M, Gotoh E.
    Jpn J Clin Oncol; 1993 Dec; 23(6):378-83. PubMed ID: 8283792
    [Abstract] [Full Text] [Related]

  • 13. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M, Fujimura M, Kawamura K, Suzuki S, Hamano M, Nishikawa Y, Nagayama T.
    Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
    [Abstract] [Full Text] [Related]

  • 14. Complete remission of renal cell carcinoma with lung metastases in two hemodialysis patients after low-dose interferon therapy.
    Nemoto K, Miura T, Shioji G, Tsuboi N.
    Hemodial Int; 2011 Apr; 15(2):288-92. PubMed ID: 21395974
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy for renal cell cancer in the era of targeted therapy.
    Coppin C.
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):907-19. PubMed ID: 18533800
    [Abstract] [Full Text] [Related]

  • 16. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE, Majer M, Boucher KM, Shrieve AF, Dechet C, Jensen RL, Shrieve DC.
    Cancer; 2008 Nov 01; 113(9):2539-48. PubMed ID: 18780316
    [Abstract] [Full Text] [Related]

  • 17. Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2).
    Huland E, Heinzer H, Huland H.
    Anticancer Res; 1999 Nov 01; 19(4A):2679-83. PubMed ID: 10470219
    [Abstract] [Full Text] [Related]

  • 18. [A case of complete regression of metastatic renal cell carcinoma following corticosteroid treatment].
    Tanaka M, Fukuda H, Higashi Y.
    Hinyokika Kiyo; 2003 Apr 01; 49(4):225-8. PubMed ID: 12784718
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.
    Culine S, Iborra F, Mottet N, Avancès C, de Graeve B, Volpé P, Vignoud J, Bringer JP, Marroncle M, Le Pellec L, Ayuso D, Jansen E, Faix A, Rebillard X.
    Am J Clin Oncol; 2006 Apr 01; 29(2):148-52. PubMed ID: 16601433
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma.
    Donskov F.
    Dan Med Bull; 2007 Nov 01; 54(4):249-65. PubMed ID: 18208677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.